GB1252401A - - Google Patents

Info

Publication number
GB1252401A
GB1252401A GB1252401DA GB1252401A GB 1252401 A GB1252401 A GB 1252401A GB 1252401D A GB1252401D A GB 1252401DA GB 1252401 A GB1252401 A GB 1252401A
Authority
GB
United Kingdom
Prior art keywords
mixtures
administered
dialkylaminoalkanols
newport
inosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1252401A publication Critical patent/GB1252401A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
GB1252401D 1969-08-28 1970-01-13 Expired GB1252401A (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85386469A 1969-08-28 1969-08-28

Publications (1)

Publication Number Publication Date
GB1252401A true GB1252401A (https=) 1971-11-03

Family

ID=25317098

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1252401D Expired GB1252401A (https=) 1969-08-28 1970-01-13

Country Status (24)

Country Link
US (1) US3646007A (https=)
JP (2) JPS493999B1 (https=)
AT (1) AT299457B (https=)
BE (1) BE755361A (https=)
BR (1) BR6915483D0 (https=)
CA (1) CA920125A (https=)
CH (1) CH530998A (https=)
CS (1) CS183616B2 (https=)
DE (2) DE1965431C3 (https=)
DK (1) DK137801B (https=)
ES (1) ES375387A1 (https=)
FR (1) FR2068522B1 (https=)
GB (1) GB1252401A (https=)
HU (1) HU162297B (https=)
IL (1) IL35135A (https=)
LU (1) LU61603A1 (https=)
NL (1) NL140735B (https=)
NO (1) NO126800B (https=)
PH (2) PH9221A (https=)
PL (1) PL80960B1 (https=)
SE (1) SE384866B (https=)
SU (1) SU381216A3 (https=)
YU (1) YU36188B (https=)
ZA (1) ZA705913B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2260331B1 (https=) * 1974-02-08 1978-01-13 Mauvernay Centre Europ Rech
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
US4387226A (en) * 1981-08-26 1983-06-07 Newport Pharmaceuticals International, Inc. Purine-dihydrothiazoles
JPS5994567U (ja) * 1982-12-15 1984-06-27 松下電工株式会社 折り畳みドアのラツチ構造
US4512981A (en) * 1982-12-20 1985-04-23 Newport Pharmaceuticals International, Inc. Method of treating inflammation using inosiplex
DE3404315C1 (de) * 1984-02-08 1985-05-09 Newport AG, Zug Verwendung von Inosin-haltigen Wirkstoffen zur Wachstumsfoerderung bei der Mast von Nutztieren
FR2652003A1 (fr) * 1989-09-20 1991-03-22 Delalande Sa Utilisation d'un complexe de l'inosine avec un n,n-dialkylamino alcanol ou un sel de celui-ci avec un acide pharmacologiquement acceptable pour le traitement de certaines infections helminthiques.
WO2005074946A1 (en) * 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
EP2912047B1 (en) 2012-10-29 2016-08-24 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
CN104744541A (zh) * 2014-05-05 2015-07-01 深圳信立泰药业股份有限公司 一种异丙肌苷新晶型、其制备方法及含有该新晶型的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB879259A (en) * 1956-11-20 1961-10-11 Riker Laboratories Inc Acid addition salts of 2-dimethylaminoethanol and central nervous system stimulant compositions containing them
US3438968A (en) * 1966-06-23 1969-04-15 Int Chem & Nuclear Corp Substituted ammonium basic addition salts of ribonucleic acid

Also Published As

Publication number Publication date
ZA705913B (en) 1971-04-28
LU61603A1 (https=) 1971-08-05
ES375387A1 (es) 1972-05-01
DK137801C (https=) 1978-10-16
YU36188B (en) 1982-02-25
IL35135A (en) 1974-07-31
JPS493999B1 (https=) 1974-01-29
FR2068522B1 (https=) 1974-08-30
DE1965431B2 (de) 1978-05-18
BE755361A (fr) 1971-03-01
CA920125A (en) 1973-01-30
YU214570A (en) 1981-04-30
NO126800B (https=) 1973-03-26
US3646007A (en) 1972-02-29
SE384866B (sv) 1976-05-24
FR2068522A1 (https=) 1971-08-27
NL140735B (nl) 1974-01-15
DE1967073C2 (de) 1986-04-17
DE1965431C3 (de) 1979-01-04
SU381216A3 (https=) 1973-05-15
BR6915483D0 (pt) 1973-03-13
DK137801B (da) 1978-05-08
PH9221A (en) 1975-07-10
DE1965431A1 (de) 1971-04-08
CH530998A (de) 1972-11-30
HU162297B (https=) 1973-01-29
PL80960B1 (en) 1975-08-30
NL7000574A (https=) 1971-03-02
IL35135A0 (en) 1970-10-30
DE1967073A1 (de) 1976-12-02
AT299457B (de) 1972-06-26
CS183616B2 (en) 1978-07-31
JPS4921765B1 (https=) 1974-06-04
PH10011A (en) 1976-07-13

Similar Documents

Publication Publication Date Title
GB1252401A (https=)
CA960003A (en) Foldable respiratory mask
GB1220133A (en) Improvements in or relating to refrigeration systems
IL35542A0 (en) New pyrazole and pyrazolopyrimidine derivatives,their production and pharmaceutical preparations containing them
ES397038A1 (es) Metodo para preparar derivados de azucar de purina.
CA920212A (en) Fuel pump safety circuitry
GB1301555A (https=)
GB980436A (en) The acid salt composed of acetyl glutamic acid and n,n-dimethylaminoethanol-1 and preparation of same
IL37121A0 (en) 1-carbamoyl-n-carbamoyloxy formimidates and their derivatives,their preparation and their use as pesticides
CA961460A (en) Safety harness-baby's high chair
Boschi QUANTITATIVE RELATIONSHIPS BETWEEN ANALYTIC AND INVENTIVE PROCESSES ASSUMED AS MEASURES OF CHARACTER IN PREADOLESCENTS OF BOTH SEXES.
IL37520A (en) S-triazines,their manufacture and their use as herbicides
ZA705254B (en) Antiviral preparations and methods
IL36097A0 (en) 2,6-bis (dialkanolamino)-pyrimido (5,4-d) pyrimidines,their preparation and pharmaceutical compositions containing them
GB1250598A (https=)
IL32504A0 (en) Quinazoline-2(1h)-thione derivatives,their preparation and pharmaceutical preparations containing them
IL22850A (en) 3-chloro-1,2,5-thiazdiazole-4-carboxylic acid being an intermediate in the preparation of sulfa drugs
Cassidy The Boletaceae of the Medicine Bow National Forest of Wyoming
IWASAKI On the System of Cultural Technics of Rice Farming in the Hachirogata Reclaimed Land
AU419307B2 (en) 2, 4, 5 TRICHLOROPYRIMIDINE and 2, 4, 5, 6 TETRACHLOROPYRIMIDINE
Pratt The notion of person in the writings of Gabriel Marcel
Toda et al. Color Perception under the Intermittent Illumination
GB1117881A (en) Improvements in or relating to firearms
ZA715B (en) Uracil phosphate and barbiturate phosphate pesticides and process for their preparation
Baker et al. Synthetic nucleosides. 68. Studies on the synthesis of cis-2, 3-diamino sugars. 8. Derivatives of 2, 3-diamino-2, 3-dideoxy-D-ribose and 2, 3-dideoxy-2, 3-imino-D-ribose

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years